DelNova Inc. is developing ReViVox, a drug aimed at mitigating the side effects of botulinum neurotoxin treatments like Botox, Dysport, Xeomin, Jeauveau, and Daxxify, commonly used for wrinkle reduction in facial aesthetics.
Integrating retail skincare into plastic surgery practices improves patient outcomes, boosts satisfaction, and supports healing. By offering medical-grade products tailored to each procedure, surgeons can provide comprehensive care while enhancing practice revenue and reputation. Learn how skincare aligns with surgical results to set new standards in patient care and practice growth.
